| 孟思妤,于亚楠,常 莉,李秀姿,李 旭,姚天明.扩张型心肌病治疗研究进展[J].,2018,(3):573-576 |
| 扩张型心肌病治疗研究进展 |
| Progression in Treatment of Dilated Cardiomyopathy |
| 投稿时间：2017-04-27 修订日期：2017-05-22 |
| DOI：10.13241/j.cnki.pmb.2018.03.039 |
| 中文关键词: 扩张型心肌病 治疗 研究进展 |
| 英文关键词: Dilated cardiomyopathy Therapy Progress |
| 基金项目:辽宁省自然科学基金项目(201602800)；中国博士后科学基金项目(2016M603067)；全军医学科技拔尖人才项目(16QNP064) |
|
| 摘要点击次数: 400 |
| 全文下载次数: 260 |
| 中文摘要: |
| 摘要：扩张型心肌病是一种以单侧或双侧心腔扩大和收缩功能障碍等为特征，治疗困难、预后较差的临床常见疾病，致病因素及临床表现复杂多样，其治疗方法一直是医学研究的热点。扩张型心肌病的治疗手段涵盖常规药物治疗及非药物治疗，后者包括手术治疗及不断发展的免疫治疗、干细胞移植和基因治疗等，且每种治疗方法都有各自的优缺点，本文针对扩张型心肌病治疗方法的最新研究进展进行综述，以期为临床治疗提供新的依据和方向，提高扩张型心肌病患者的生活质量和生存率。 |
| 英文摘要: |
| ABSTRACT: Dilated cardiomyopathy, characterized by unilateral or bilateral chamber dilatation and contraction dysfunction, is a common disease with difficulty in treatment and poor prognosis. Both pathogenic factors and clinical symptoms are complicated and di- verse. Thus, the treatment has been a hot point in the field of medical research. Dilated cardiomyopathy treatment covers routine drug and non-drug treatments including surgery and evolving immunotherapy, stem cell transplantation, gene therapy and so on. Each of them has its own advantages and disadvantages. This review summarizes the recent progresses in treatment of dilated cardiomyopathy, aiming to provide basis and direction to clinical treatment, as well as improve life quality and survival rate of patients. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
